California Oncology Weekly Newsletter 1.31.2017

The Office of Environmental Health Hazard Assessment (OEHHA) is adding Pertuzumab (CAS No. 380610-27-5) to the list of chemicals known to the state to cause reproductive toxicity (developmental endpoint), and Vismodegib (CAS No. 879085-55-9) to the list of chemicals known to the state to cause reproductive toxicity (developmental, female and male endpoints), for purposes of Proposition 65.  For more information click here and go under California News.

The CMA has received eight resolutions for consideration in the second quarter (Q2) of the Year-Round Resolution Process. The Resolutions will be posted online. The testimony period will be open from February 13 to March 13. After testimony closes, the Council or Subcommittee to which each resolution has been assigned will consider it. For more information click here and go under California News.

The Medicare Participating Physician Directory (MEDPARD) is a list of physicians, suppliers and practitioners (Medicare health care providers) who have signed an agreement to accept assignment on all claims. When a Medicare provider accepts assignment, they agree to accept the Medicare approved amount as payment in full for a covered service and can only bill the patient for deductible, coinsurance, and any non-covered services. Participating providers should visit the MEDPARD directory to check their practice information for accuracy. For more information click here and go under Noridian News.

An American Medical Association (AMA)-led coalition including ASCO and 15 other health care organizations are urging health plans, benefit managers, and other stakeholders to reform utilization management policies, including prior authorization requirements, imposed on medical tests, procedures, devices, and drugs. For more information click here and go under National News.

To view the complete California Oncology Weekly Newsletter, click on the date below.

January 31, 2017.

This week is National Medical Group Practice Week, from Jan. 23-27, recognizing the important work medical group practices’ do every day. That’s right, there’s a whole week dedicated to our profession!

Under a law passed by the California Legislature in 2016, checking the Controlled Substance Utilization Review and Evaluation System (CURES) database will eventually be mandatory. For more information click here and go under California News.

There is a change to Medi-Cal’s “Estate Recovery Program” that can demand posthumous payback from enrollees 55 and over for a broad range of medical costs. The federal government requires states to recoup specific medical costs — mostly related to nursing home care — from the estates of certain Medicaid beneficiaries after they die. California is among a minority of states that seeks repayment beyond the federal mandate.  For more information click here and go under DHCS/Medi-Cal News.

The United States Food and Drug Administration (FDA) has released the final guidance for industry on the Nonproprietary Naming of Biological Products. Under the naming convention, FDA will designate a distinguishing suffix that is devoid of meaning and composed of four lower-case letters in the non-proprietary names for originator biological products, related biological products, and biosimilar products. For more information click here and go under National News.

The Centers for Medicare & Medicaid Services (CMS) updated the Open Payments dataset to reflect changes to the data that took place since the last publication on June 30, 2016.  For more information click here and go under CMS News.

CMS is now accepting applications, through January 31, for a new Clinical Practice Improvement Activities (CPIA) study, which will examine workflow and data collection methods so that CMS can better understand the challenges of collecting and reporting quality data. For more information click here and go under CMS News.

To view the complete California Oncology Weekly Newsletter, click on the date below.

January 24, 2017

California doctors thought they would see higher Medi-Cal reimbursement rates from revenue raised by the new tax, but Gov. Jerry Brown’s budget directs that the funds instead cover other increases for the program. Doctors have long argued that the money they receive for serving Medi-Cal patients isn’t enough to sustain a practice, leading to a shortage of medical providers willing to treat California’s poorest residents in rural communities and other pockets of the state. For more information click here and go under California News.

The California Dialogue on Cancer is excited to announce the addition of the CDOC Stakeholder Spotlight program, to recognize those CDOC stakeholders who have gone above and beyond to make a difference in cancer control efforts. The CDOC Project Spotlight program promotes CDOC projects, interventions, and other cancer-related activities. For more information click here and go under California News.

For 2017, a new CPT procedure code (96377) was developed and published for the application of an on-body injector for timed subcutaneous injection. Unfortunately, 96377 did not originally appear in the Medicare Part B fee schedule and the January update included it with an “Inactive” rather than a “Contractor Priced” code. For more information click here and go under Noridian News.

The Food and Drug A dministration and the Office of Human Research recently published final guidance on how to use electronic systems and processes to obtain informed consent in clinical investigations. For more information click here  and go under National News.

Applications are now being accepted for ASCO’s Quality Training Program . This comprehensive 6-month program is oncology-focused and teaches clinicians how to improve quality using evidence-based decisions and how to reduce clinical and process variation for predictable and sustainable results. For more information click here and go under Affiliate Association News.

To view the complete California Oncology Weekly Newsletter, click on the date below.

January 17, 2017

In speeches on the West Coast, Vice President Joe Biden says he will continue his campaign to find cures for cancer and extolled young researchers to find new remedies through their “overwhelming skepticism for orthodoxy.” For more information click here and go under California News.

The California Dialogue on Cancer is excited to announce the addition of the CDOC Stakeholder Spotlight program, to recognize those CDOC stakeholders who have gone above and beyond to make a difference in cancer control efforts. For more information click here and go under California News.

MOASC President Warren H. Fong, M.D. sits on the Medi-Cal ORP (Ordering, Referring, and Prescribing) Stakeholder Council and would like to share the recent December 22, 2016 meeting with you. For more information click here and go under DHCS/Medi-Cal News.

SB 1004 requires DHCS to establish standards and provide technical assistance for Medi-Cal managed care plans for the delivery of palliative care services.  DHCS released an updated palliative care policy document and data analysis on September 1, 2016.  For more information click here and go under DHCS/Medi-Cal News.

CMS is now accepting applications for a new Clinical Practice Improvement Activities (CPIA) study, which will examine workflow and data collection methods so that CMS can better understand the challenges of collecting and reporting quality data.  For more information click here and go under CMS News.

To view the complete California Oncology Weekly Newsletter click  on the date below.

January 10, 2017

MOASC physician members are invited to take advantage of an opportunity to conduct a research study in the community oncology setting and insure continued practice in the setting of their choice.  The goal of this project is to show the value of a physician dispensing practice within a community setting.  For more information click here and go under MOASC News.

On December 30, 2016, the DMHC released the Uniform Provider Directory Standards required under SB 137 (Hernandez, Chapter 649, Statutes of 2015). The DMHC and the California Department of Insurance (CDI) held a public meeting on the development of the standards on November 29, 2016. For more information click here and go under DHCS/Medi-Cal News.

In October 2016, the DMHC launched the Health Plan Dashboard, an online tool to make health plan data more transparent and accessible to the public. The Health Plan Dashboard aggregates more than a dozen public data sets reported by health plans and the DMHC. For more information click here and go under DHCS/Medi-Cal News.

Oncology Revolution:  Are your treatment choices still relevant in the era of Immuno-oncology and Molecularly-targeted therapies? Join us for the 2017 MOASC Oncology Summit of Nationally known and regionally based key-opinion leaders and assess your tools for thriving in an era of Personalized Medicine.  For more information click here and go under MOASC News.

The notice for the Special Open Door Forum, regarding Social Security Number Removal Initiative (SSNRI) impacts upon Medicare Secondary Payer (MSP) stakeholders, is available in the Downloads section of the Coordination of Benefits and Recover. For more information click here and go under CMS News.

To view the complete California Oncology Weekly Newsletter click on the date below.

January 3, 2017